Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Guillaume, Grenet"'
Autor:
Florie Bouvier, Anna Chaimani, Etienne Peyrot, François Gueyffier, Guillaume Grenet, Raphaël Porcher
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background One key aspect of personalized medicine is to identify individuals who benefit from an intervention. Some approaches have been developed to estimate individualized treatment effects (ITE) with a single randomized control trial (RC
Externí odkaz:
https://doaj.org/article/84138b58838a4f71989c3d8928452eed
Autor:
Giuseppe Balice, Maxime Boksebeld, Quentin Barrier, Sara Boccalini, Behrouz Kassai-Koupai, Nathalie Paret, Guillaume Grenet
Publikováno v:
Toxins, Vol 16, Iss 6, p 265 (2024)
We encountered a case of mushroom intoxication complicated by “toxic-like” myocarditis. Because of the lack of systematized knowledge on this subject, we performed a systematic review of the literature on cardiac toxicity in mushroom poisoning (M
Externí odkaz:
https://doaj.org/article/a56804e442484497b5877b67d7521e7d
Publikováno v:
HemaSphere, Vol 7, p e62941c4 (2023)
Externí odkaz:
https://doaj.org/article/549c44bd56804028b1e1bd4a293cb445
Autor:
Roubi Kilo, Silvy Laporte, Rama Arab, Sabine Mainbourg, Steeve Provencher, Guillaume Grenet, Laurent Bertoletti, Laurent Villeneuve, Michel Cucherat, Jean-Christophe Lega, META-EMBOL Group
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract This study aimed to explore the validity of the use of the net clinical benefit (NCB), i.e. the sum of major bleeding and thrombotic events, as a potential surrogate for all-cause mortality in clinical trials assessing antithrombotics. Publi
Externí odkaz:
https://doaj.org/article/6ede1d7ffd7e45c089cbac448dc01abd
Autor:
S Bally, J Cottin, M C Gagnieu, J C Lega, C Verstuyft, S Rheims, G Lesca, M Cucherat, Guillaume Grenet
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278839 (2022)
Publication bias may lead to a misestimation in the association between pharmacogenetic biomarkers (PGx) and antiseizure drug's adverse effects (AEs). We aimed to assess its prevalence in this field. We searched for systematic reviews assessing PGx o
Externí odkaz:
https://doaj.org/article/f7e12b2723c74a1bb220ae372768511a
Autor:
Behrouz Kassai, Philippe Bouyé, Brigitte Gilbert-Dussardier, François Godart, Jean-Benoit Thambo, Massimiliano Rossi, Pierre Cochat, Pierre Chirossel, Stephane Luong, André Serusclat, Isabelle Canterino, Catherine Mercier, Muriel Rabilloud, Christine Pivot, Fabrice Pirot, Tiphanie Ginhoux, Stéphanie Coopman, Guillaume Grenet, François Gueyffier, Sylvie Di-Fillippo, Aurélia Bertholet-Thomas
Publikováno v:
BMC Pediatrics, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Insufficient elastin synthesis leads to vascular complications and arterial hypertension in children with Williams-Beuren syndrome. Restoring sufficient quantity of elastin should then result in prevention or inhibition of vascula
Externí odkaz:
https://doaj.org/article/13393c5d8f8d45d48755e9b136fa449a
Autor:
Gaël Le Roux, Guillaume Grenet, Corinne Schmitt, French Poison Control Centers Research Group, Sébastien Larréché, Alexis Descatha
Publikováno v:
Toxins, Vol 14, Iss 8, p 570 (2022)
We aimed to make an exhaustive assessment of circumstances of bites by exotic reptiles bred in France. A retrospective observational study was conducted in all the reported cases from 2000 to 2020 in French poison control centers (PCCs). Two hundred
Externí odkaz:
https://doaj.org/article/6f138d174bd64cd5a94067b4ed2b3d28
Autor:
Mor Fall, Hai-Ha Le, Agathe Bouvier, Célia Louis, Emeline Elias, Karam Yacoub, Muaamar Al-Gobari, Guillaume Grenet, Mamadou Seye, Gaëlle Simeon, Amadou Moctar Dieye, François Gueyffier
Publikováno v:
Therapies. 77:663-672
To explore whether preventive cardiovascular drugs (antihypertensive, antiplatelet, lipid lowering and hypoglycemic agents) interact together in cardiovascular prevention.We searched PubMed®, Web of science™, Embase and Cochrane library for powerf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb23b9acadbf14e883e3bafad601fb00
https://doi.org/10.1016/j.therap.2022.04.004
https://doi.org/10.1016/j.therap.2022.04.004
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis.
Autor:
Guillaume Grenet, Shams Ribault, Giao Bao Nguyen, Faustine Glais, Augustin Metge, Thomas Linet, Behrouz Kassai-Koupai, Catherine Cornu, Théodora Bejan-Angoulvant, Sylvie Erpeldinger, Rémy Boussageon, Aurore Gouraud, Fabrice Bonnet, Michel Cucherat, Philippe Moulin, François Gueyffier
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217701 (2019)
BackgroundThe last international consensus on the management of type 2 diabetes (T2D) recommends SGLT-2 inhibitors or GLP-1 agonists for patients with clinical cardiovascular (CV) disease; metformin remains the first-line glucose lowering medication.
Externí odkaz:
https://doaj.org/article/b80e052c1b1248caae71b05d7b6683f6
Autor:
Mor Fall, Guillaume Grenet, Hai-Ha Le, Behrouz Kassaï, Jean-Christophe Lega, Rémy Boussageon, Sabine Mainbourg, Ivanny Marchant, Johanne Gafsi, Amadou Moctar Dieye, François Gueyffier
Publikováno v:
Therapies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d42a894fd71f6f78d045cd20ae6506aa
https://doi.org/10.1016/j.therap.2023.01.011
https://doi.org/10.1016/j.therap.2023.01.011